EXPLANATORY NOTE
This Amendment No. 1 (“Amendment No. 1”) amends the prospectus/offer to exchange, dated November 10, 2022 (as it may be amended and supplemented from time to time, the “Prospectus/Offer to Exchange”), a copy of which was filed as Exhibit (a)(1)(A) to the Tender Offer Statement on Schedule TO originally filed by Super Group (SGHC) Limited, a non-cellular company limited by shares incorporated under the laws of the Island of Guernsey (the “Company”), on November 10, 2022 (as it may be amended and supplemented from time to time, the “Schedule TO”), relating to an offer by the Company to each holder of the Company’s outstanding public warrants (as defined below) to receive 0.25 ordinary shares of the Company, no par value per share (“Ordinary Shares”) in exchange for every outstanding public warrant tendered by the holder and exchanged pursuant to the offer (the “Offer”).
The 22,499,986 redeemable warrants sold as part of the units in Sports Entertainment Acquisition Corp.’s (“SEAC”) initial public offering of SEAC’s securities on October 6, 2020 (the “IPO”) (whether they were purchased in the IPO or thereafter in the open market) are referred to herein as the “public warrants”. The warrants originally issued to certain investors in a private placement simultaneously with the closing of the IPO, as well as in connection with the closing of the partial exercise by the underwriters of their over-allotment option, that have not become public warrants under the Warrant Agreement (as defined below) as a result of being transferred to any person other than permitted transferees are referred to herein as the “private placement warrants”, and were issued pursuant to certain subscription agreements, each in connection with the closing of the transactions contemplated by the business combination agreement, dated as of April 23, 2021, by and among SEAC and the Company, et al.
The public warrants and the private placement warrants are referred to herein collectively as the “warrants”, and each a “warrant”.
Concurrently with the Offer, the Company is also soliciting consents (the “Consent Solicitation”) from holders of the outstanding warrants to amend that certain Warrant Agreement, dated as of October 6, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”), to permit the Company to (i) require that all outstanding public warrants following this Offer be converted into 0.225 Ordinary Shares (a ratio 10% less than the exchange ratio applicable to the Offer) and (ii) instruct the warrant agent to cancel each outstanding private placement warrant for no consideration (the “Warrant Amendment”).
The Prospectus/Offer to Exchange, a copy of which is filed herewith as Exhibit (a)(1)(A), is amended to, among other things, (i) clarify that all offer conditions must be satisfied or waived as of the expiration of the offer, (ii) remove the limitation on prices for securities in U.S. securities or financial markets as a condition to the Offer, (iii) clarify that the Company’s action or inaction may not cause a failure of a condition to the Offer, (iv) clarify that upon occurrence of an event that implicates a condition to the Offer, the Company will promptly notify warrant holders of whether it intends to waive the condition, (v) remove language related to the Company’s reservation of the right to redeem the warrants, (vi) include as an exhibit the press release issued by the Company on November 22, 2022 with the Company’s third quarter 2022 financial results, and (vii) furnish updated Interactive Data (XBRL) files as Exhibit 101, in accordance with Rule 405 of Regulation S-T. In accordance with (v) above, corresponding edits have been made to other exhibits to this Schedule TO and to the Prospectus/Offer to Exchange to remove language related to the Company’s reservation of rights to redeem the warrants. No other changes have been made to the Prospectus/Offer to Exchange or the financial statements contained therein as originally filed on November 10, 2022.
Except as amended hereby to the extent discussed above, the information contained in the Schedule TO, the Prospectus/Offer to Exchange, and the other exhibits to the Schedule TO remains unchanged and is hereby expressly incorporated into this Amendment No. 1 by reference. This Amendment No. 1 should be read with the Schedule TO and the Prospectus/Offer to Exchange.
1